Bitenza drug is combination of two active substances: perindopril and amlodipine. It is administered for cure of higher arterial tension (arterial hypertension).
Perindopril is part of drug class called inhibitors of angiotensin converting enzyme (ATE). Amlodipine is calcium antagonist (drug class called dihydropyridine). Their combined action results in dilatation and relaxation of blood vessels and relief of cardiac function.
Every active substance of Bitenza drug decreases arterial pressure, and in combination they control AP.
Indications for usage:
• Arterial hypertension and/or
• Stable cardiac ischemia.
Advantages of Bitenza drug
• Effective and rational combination of antihypertensive agents
• One medicine for two diseases (AP and CI)
• Duration of action 1 day and over
• Friendly use 1 capsule 1 time daily
• Affordable price.
Bitenza drug was included in Republican Module of Drugs approved by Ministry of healthcare of the Republic of Belarus 18/04/2023 under N.54 and in List of Principle Drugs approved by Decree of Ministry of healthcare of the Republic of Belarus 18/04/2023 under N.55
On sale from the end of May-beginning of June,2024.
Contraindications and undesirable reactions. Do not administer in the 1st trimester of pregnancy and lactation. Contraindicated in the 2nd and 3rd trimester of pregnancy.
READ LEAFLET BEFORE USE